Grant: Project Grant
Université Laval
$100,000.00
activated CHARcoal in Poisoned Patients (CHARPP): a pilot Randomized Controlled Trial
EF 2022-23
Résumé
Poisonings represent an important social burden. In 2018, unintentional poisonings in Canada were responsible for 3,477 deaths, 10,772 hospital admissions and 79,231 emergency department visits. Activated charcoal is one of the interventions most frequently recommended by poison centers. For instance, in 2020, 32,646 poisoned patients were treated with activated charcoal in the United States. This treatment has the potential to prevent toxicity and decrease its severity. However, its use may also cause nausea, vomiting, and serious breathing difficulties.
Therefore, we developed a research program named CHARPP (activated CHARcoal in Poisoned Patients). CHARPP aims to describe the risks and benefits associated with the use of activated charcoal. The current grant concerns the CHARPP pilot trial, which evaluates the feasibility of a large-scale trial involving many centres. It will determine our capacity to recruit participants, respect the research protocol and follow participants long enough to document outcomes such as progression of toxicity, mortality and adverse events.
The results of this pilot trial will allow us to evaluate the feasibility of a large trial. It will also be an excellent opportunity to develop collaborations between key players that will be involved in the large trial. The results of the CHARPP research program could influence policy, poison center recommendations, clinician practice and improve patient outcomes.
Programme
Project Grant
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
477334
Name
St-Onge Maude
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Randomized Controlled Trials 2
Projecttitle
activated CHARcoal in Poisoned Patients (CHARPP): a pilot Randomized Controlled Trial
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Activated Charcoal; Clinical Trial; Decontamination; Intoxication; Poisoning; Toxicology
Abstract
Poisonings represent an important social burden. In 2018, unintentional poisonings in Canada were responsible for 3,477 deaths, 10,772 hospital admissions and 79,231 emergency department visits. Activated charcoal is one of the interventions most frequently recommended by poison centers. For instance, in 2020, 32,646 poisoned patients were treated with activated charcoal in the United States. This treatment has the potential to prevent toxicity and decrease its severity. However, its use may also cause nausea, vomiting, and serious breathing difficulties.
Therefore, we developed a research program named CHARPP (activated CHARcoal in Poisoned Patients). CHARPP aims to describe the risks and benefits associated with the use of activated charcoal. The current grant concerns the CHARPP pilot trial, which evaluates the feasibility of a large-scale trial involving many centres. It will determine our capacity to recruit participants, respect the research protocol and follow participants long enough to document outcomes such as progression of toxicity, mortality and adverse events.
The results of this pilot trial will allow us to evaluate the feasibility of a large trial. It will also be an excellent opportunity to develop collaborations between key players that will be involved in the large trial. The results of the CHARPP research program could influence policy, poison center recommendations, clinician practice and improve patient outcomes.
Competitiondate
202210
Approvedterm2
1 yr 0 mth
Pinamesdelim
St-Onge, Maude; Elliott, Audrée
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~